Comparison of efficacy of long-acting bronchodilators in emphysema dominant and emphysema nondominant chronic obstructive pulmonary disease

International Journal of COPD

Volumn 6, Issue 1, 2011, Pages 219-227

  Fujimoto, Keisaku ^a   Kitaguchi, Yoshiaki ^a   Kanda, Shintaro ^a   Urushihata, Kazuhisa ^a   Hanaoka, Masayuki ^a   Kubo, Keishi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Agonist; Dynamic hyperinfation; Emphysema; Exercise capacity; Long acting 2; Long acting muscarinic antagonist; Quality of life

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; LONG ACTING DRUG; SALMETEROL; SHORT ACTING DRUG; THEOPHYLLINE; TIOTROPIUM BROMIDE; DRUG DERIVATIVE; MUSCARINIC RECEPTOR BLOCKING AGENT; SALBUTAMOL; SCOPOLAMINE DERIVATIVE;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG EFFECT; DRUG EFFICACY; DYSPNEA; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HYPERINFLATION; INSPIRATORY CAPACITY; LUNG EMPHYSEMA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHENOTYPIC VARIATION; QUALITY OF LIFE; RESPIRATORY AIRFLOW; RETROSPECTIVE STUDY; THERAPEUTIC HYPERVENTILATION; TREATMENT DURATION; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONVALESCENCE; EXERCISE TEST; HOSPITALIZATION; JAPAN; LUNG; LUNG FUNCTION TEST; PATHOPHYSIOLOGY; PHENOTYPE; TIME; TREATMENT OUTCOME;

ADRENERGIC BETA-2 RECEPTOR AGONISTS; AGED; ALBUTEROL; BRONCHODILATOR AGENTS; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; JAPAN; LUNG; MALE; MUSCARINIC ANTAGONISTS; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; QUALITY OF LIFE; RECOVERY OF FUNCTION; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SCOPOLAMINE DERIVATIVES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 80053534324     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S18461     Document Type: Article

References (23)

1. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO workshop report. Bethesda, National Heart, Lung and Blood Institute, April 2001; Update of the Management Sections. Available at: http://www.goldcopd.com. Accessed March 16, 2011.
2. Nakano Y, Muro S, Sakai H, et al. Computed tomographic measurements of airway dimensions and emphysema in smokers: Correlation with lung function. Am J Respir Crit Care Med. 2000;162:1102-1108.
3. Gelb AF, Zamel N, Hogg JC, Muller NL, Schein MJ. Pseudophysiologic emphysema resulting from severe small-airways disease. Am J Respir Crit Care Med. 1998;158:815-819.
4. Kitaguchi Y, Fujimoto K, Kubo K, Honda T. Characteristics of COPD phenotypes classified according to the findings of HRCT. Respir Med. 2006;100:1742-1752.
5. Fujimoto K, Kitaguchi Y, Kubo K, Honda T. Clinical analysis of chronic obstructive pulmonary disease phenotypes classified using high-resolution computed tomography. Respirology. 2006; 11:731-740.
6. O'Donnel DE, Bertley JC, Chau LK, Webb KA. Qualitative aspects of exertional breathlessness in chronic airflow limitation. Am J Respir Crit Care Med. 1997;155:109-115.
7. O'Donnell DE, Revill SM, Webb KA. Dynamic hyperinfation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164:770-777.
8. Belman MJ, Botnick WC, Shin J W. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996; 153:967-975.
9. Barr RG, Bourbeau J, Camargo CA, Ram FS. Inhaled tiotropium for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2005;CD002876.
10. Donohue JF, van Noord JA, Bateman ED, et al. A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. Chest. 2002; 122:47-55.
11. ATS Committee on Profciency Standards for Clinical Pulmonary Function Laboratories. ATS Statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111-117.
12. Goddard PR, Nicholson EM, Laszlo G, Watt I. Computed tomography in pulmonary emphysema. Clin Radiol. 1982;33:379-387.
13. Japanese Society of Chest Disease. Standards of pulmonary function tests for Japanese. Jpn J Respir Dis. 1993;31:421-427.
14. Nishida O, Kambe M, Sewake N, et al. Pulmonary function in healthy subjects and its prediction: 5. Pulmonary diffusing capacity in adults. Jpn J Clin Pathol. 1976;24:941-947.
15. Boren HG, Kory RC, Syner JC, Callahan R. The Veterans Administration-Army cooperative study of pulmonary function. 2. The lung volume and its subdivisions in normal men. Am J Med. 1966;41:96-101.
16. Van de Woestijne K P, Desager KN, Duiveman EJ, Marchal F. Recommendations for measurement of respiratory input impedance by means of the forced oscillation method. Eur Respir Rev. 1994;19:235-237.
17. Kanda S, Fujimoto K, Komatsu Y, Yasuo M, Hanaoka M, Kubo K. Evaluation of respiratory impedance in asthma and COPD by an impulse oscillation system. Intern Med. 2010;49:23-30.
18. Fujimoto K, Yoshiike F, Yasuo M, et al. Effects of bronchodilators on dynamic hyperinfation following hyperventilation in patients with COPD. Respirolog y. 2007;12:93-1299.
19. Casaburi R, Mahler DA, Jones P W, et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J. 2002;19:217-224.
20. Gelb A F, Gutierrez CA, Weisman IM, Newsom R, Taylor C F, Zamel N. Simplified detection of dynamic hyperinflation. Chest. 2004;126:1855-1860.
21. O'Donnell DE, Fluge T, Gerken F, et al. Effects of tiotropium on lung hyperinfation, dyspnea and exercise tolerance in COPD. Eur Respir J. 2004;23:832-840.
22. Gelb A F, Taylor CF, Cassino C, Shinar CM, Schein MJ, Zamel N. Tiotropium induced bronchodilation and protection from dynamic hyperinfation is independent of extent of emphysema in COPD. Pulm Pharmacol Ther. 2009;22:237-242.
23. O'Donnell DE, Lam M, Webb KA. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160:542-549.